Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Eiermann

Showing results (81-90 of 109) with videos related to

Pageof 11
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxelG von Minckwitz, S D Costa, W Eiermann, et al.
Digitale Bilddiagnostik|September 1, 1987
[Radioimmunoscintigraphy with monoclonal antibodies]K Scheidhauer, M Landthaler, H Denecke, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Cholesterol in the urine in malignant diseases]D Jüngst, A Stadler, A Pickel, et al.
Journal of Medical Economics|September 13, 2012
Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German settingJ U Blohmer, M Rezai, S Kümmel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
Statistical controversies in clinical research: statistical significance-too much of a good thing …M Buyse, S A Hurvitz, F Andre, et al.
Drugs|January 1, 1992
Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapyU Bruntsch, S Drechsler, E Hiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial GroupM Kaufmann, W Jonat, U Kleeberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancerW Jonat, A Howell, C Blomqvist, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancerW Jonat, M Kaufmann, R W Blamey, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) studyV Semiglazov, W Eiermann, M Zambetti, et al.
Pageof 11

Showing results (81-90 of 109) with videos related to

Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Maximized reduction of primary breast tumor size using preoperative chemotherapy with doxorubicin and docetaxelG von Minckwitz, S D Costa, W Eiermann, et al.
Digitale Bilddiagnostik|September 1, 1987
[Radioimmunoscintigraphy with monoclonal antibodies]K Scheidhauer, M Landthaler, H Denecke, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1978
[Cholesterol in the urine in malignant diseases]D Jüngst, A Stadler, A Pickel, et al.
Journal of Medical Economics|September 13, 2012
Using the 21-gene assay to guide adjuvant chemotherapy decision-making in early-stage breast cancer: a cost-effectiveness evaluation in the German settingJ U Blohmer, M Rezai, S Kümmel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 11, 2016
Statistical controversies in clinical research: statistical significance-too much of a good thing …M Buyse, S A Hurvitz, F Andre, et al.
Drugs|January 1, 1992
Prevention of chemotherapy-induced nausea and emesis in patients responding poorly to previous antiemetic therapy. Comparing tropisetron with optimised standard antiemetic therapyU Bruntsch, S Drechsler, E Hiller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1989
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial GroupM Kaufmann, W Jonat, U Kleeberg, et al.
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancerW Jonat, A Howell, C Blomqvist, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
A randomised study to compare the effect of the luteinising hormone releasing hormone (LHRH) analogue goserelin with or without tamoxifen in pre- and perimenopausal patients with advanced breast cancerW Jonat, M Kaufmann, R W Blamey, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 17, 2011
Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) studyV Semiglazov, W Eiermann, M Zambetti, et al.
Pageof 11